Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/23/2012US20120214783 Viral polymerase inhibitors
08/23/2012US20120214782 New compounds, pharmaceutical compositions and uses thereof
08/23/2012US20120214781 Antibacterial Food Composition
08/23/2012US20120214780 Substituted porphyrins
08/23/2012US20120214779 Application of 20(s)-protopanaxadiol in preparation of antidepressants
08/23/2012US20120214778 FULVESTRANT IN A DOSAGE OF 500mg FOR THE TREATMENT OF ADVANCED BREAST CANCER
08/23/2012US20120214777 Stabilized compositions containing alkaline labile drugs
08/23/2012US20120214776 Topical formulations comprising a steroid
08/23/2012US20120214775 Pharmaceutical Salts of 3-O-(3',3'-Dimethylsuccinyl) Betulinic Acid
08/23/2012US20120214774 Treatment of solid tumors with rapamycin derivatives
08/23/2012US20120214773 Formulation for lipophilic agents
08/23/2012US20120214772 Compositions for treatment of inflammatory diseases
08/23/2012US20120214771 Compositions for treatment of cardiometabolic disorders
08/23/2012US20120214770 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
08/23/2012US20120214769 Novel Antagonists of the Glucagon Receptor
08/23/2012US20120214768 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
08/23/2012US20120214767 Tricyclic heterocyclic compounds
08/23/2012US20120214766 Cannabinoid receptor modulators
08/23/2012US20120214765 Boron-containing small molecules as anti-inflammatory agents
08/23/2012US20120214764 Method and kit for gastro-intestinal cleansing
08/23/2012US20120214763 Memory fixation accelerator
08/23/2012US20120214762 6,5-heterocyclic propargylic alcohol compounds and uses therefor
08/23/2012US20120214761 Pre-mixed, ready-to-use iv bolus nicardipine compositions and methods of use
08/23/2012US20120214760 Treatment of urinary tract infections with antibacterial aminoglycoside compounds
08/23/2012US20120214759 Treatment of klebsiella pneumoniae infections with antibacterial aminoglycoside compounds
08/23/2012US20120214758 Tyrosine kinase receptor antagonists and methods of treatment for pancreatic cancer
08/23/2012US20120214757 Methods and Compositions for Treating Cancer Using Proteasome Inhibitors
08/23/2012US20120214756 Cooperative conveyance of basic active principles by amphiphilic acid molecules
08/23/2012US20120214755 Methods of producing and using nutritional and pharmaceutical compositions that include one or more active substances
08/23/2012US20120214754 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof
08/23/2012US20120214753 Pharmaceutical composition for oral administration
08/23/2012US20120214752 Glucosyl Stevia Composition
08/23/2012US20120214751 Glucosyl Stevia Composition
08/23/2012US20120214742 Gaba release-regulating agent in cerebellum
08/23/2012US20120214736 Compositions and methods for the modulation of jnk proteins
08/23/2012US20120214735 Acetamide derivatives as glucokinase activators, their process and medicinal applications
08/23/2012US20120214734 Treatment of metabolic disorders
08/23/2012US20120213996 Allergen-inhibiting fibers
08/23/2012US20120213872 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
08/23/2012US20120213869 Pain Relieving Composition
08/23/2012US20120213867 Raf inhibitors for the treatment of thyroid cancer
08/23/2012US20120213855 Dosage forms for weakly ionizable compounds
08/23/2012US20120213851 Solid pharmaceutical compositions containing an integrase inhibitor
08/23/2012US20120213850 Controlled Release and Taste Masking Oral Pharmaceutical Composition
08/23/2012US20120213845 Skin composition comprising an exfoliate, a brightener and a collagen booster, and method of using the same
08/23/2012US20120213844 Liposome composition for targeting egfr receptor
08/23/2012US20120213842 Methods of making and using compositions comprising flavonoids
08/23/2012US20120213838 Medical device for placement into a lumen and manufacturing method thereof
08/23/2012US20120213837 Compositions and methods for bioactive coatings to improve allograft incorporation
08/23/2012US20120213835 Compositions Comprising Peroxy alpha-Ketocarboxylic Acid and Methods For Producing and Using the Same
08/23/2012US20120213832 Removable dental curable composition
08/23/2012US20120213831 Microspheres for active embolization
08/23/2012US20120213830 Suspension comprising benzimidazole carbamate and a polysorbate
08/23/2012US20120213829 Dry powder aerosols of nanoparticulate drugs
08/23/2012US20120213827 Process for controlled crystallization of an active pharmaceutical ingredient from supercooled liquid state by hot melt extrusion
08/23/2012US20120213825 Antibiotic product, use and formulation thereof
08/23/2012US20120213824 Use of pufas for treating skin inflammation
08/23/2012US20120213823 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
08/23/2012US20120213822 Chemo-immunotherapy method
08/23/2012US20120213807 Neprilysin inhibitors
08/23/2012US20120213806 Neprilysin inhibitors
08/23/2012US20120213802 PAR-1 Antagonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections
08/23/2012US20120213800 Methods for treating and diagnosing disease
08/23/2012US20120213798 Methods and uses for treating hepatic ischemia and reperfusion injury
08/23/2012US20120213795 Compositions and methods for inhibition of the jak pathway
08/23/2012US20120213791 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
08/23/2012US20120213790 Methods of treatment using il-16 antagonist peptides
08/23/2012US20120213788 Use of inhibitors of leukotriene b4 receptor blt2 for treating human cancers
08/23/2012US20120213778 Method of detecting and treating tuberous sclerosis complex associated disorders
08/23/2012US20120213772 Metabolic biomarkers of Crohn's Disease
08/23/2012US20120213769 Methods of diagnosing amyotrophic lateral sclerosis (als)
08/23/2012US20120213768 Diagnostic and Therapeutic Uses for B Cell Maturation Antigen
08/23/2012US20120213766 Anticancer Compounds from Vernonia Guineensis
08/23/2012US20120213758 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
08/23/2012US20120213757 Nutritional supplement composition
08/23/2012US20120213742 Virus growing in hypoxic cell or virus vector expressing gene therein
08/23/2012US20120213737 Compositions and methods for therapeutic membrane repair
08/23/2012US20120213736 Parvovirus methods and compositions for killing neoplastic cells
08/23/2012US20120213735 Therapeutic furopyrimidines and thienopyrimidines
08/23/2012US20120213733 Anti-infective agents and uses thereof
08/23/2012US20120213731 Methods and compositions for treating autoimmune diseases
08/23/2012US20120213729 Compounds for the Treatment of Hepatitis C
08/23/2012US20120213727 Therapeutic uses of oligomeric and polymeric monoterpenes
08/23/2012US20120213717 Soothing Agents
08/23/2012US20120213713 Compositions of omega fatty acids for the prevention and treatment of dental caries resulting from oral infections
08/23/2012US20120213707 Riboflavin Based Aerosol and Use as Placebo in Trials
08/23/2012US20120213702 Novel diagnostic agents for the non-invasive in vivo imaging of aminopeptidase n (apn/cd13)
08/23/2012DE102010048476A1 Hybridverbindungen aus 4- und 8-Aminochinolinen zur prophylaktischen und therapeutischen Behandlung von Malaria und anderen parasitären Erkrankungen Hybrids consisting of 4- and 8-aminoquinolines for prophylactic and therapeutic treatment of malaria and other parasitic diseases
08/23/2012CA2829045A1 Compounds and methods for treatment of hypertension
08/23/2012CA2828047A1 Steroid alkaloids and uses thereof as antimicrobial agents against electron transport-deficient microbes and as potentiators for antimicrobial agents against pathogenic bacteria
08/23/2012CA2827724A1 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
08/23/2012CA2827715A1 Methods and compositions for treating, reducing, or preventing damage to the nervous system of animals
08/23/2012CA2827679A1 Methods for synthesizing molybdopterin precursor z derivatives
08/23/2012CA2827673A1 Mtor/jak inhibitor combination therapy
08/23/2012CA2827643A1 Treatment of submental fat
08/23/2012CA2827585A1 Statin and omega 3 fatty acids (epa, dha and dpa) for use in cardiovascular diseases
08/23/2012CA2827579A1 Omega 3 formulations comprising epa, dha and dpa for treatment of risk factors for cardiovascular disease
08/23/2012CA2827577A1 A formulations comprising omega 3 fatty acids and an anti obesity agent for the reduction of body weight in cardiovascular disease patients (cvd) and diabetics
08/23/2012CA2827561A1 Omega 3 fatty acid diagniostic assay for the dietary management of patients with cardiovascular disease (cvd)
08/23/2012CA2827555A1 Cholesterol absorption inhibitor (azetidinone) and omega 3 fatty acids (epa, dha, dpa) for the reduction of cholesterol and for the reduction of cardiovascular events
1 ... 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 ... 7860